Not trying to be rude but I think you have put a v
Post# of 56323
I see it differently. There must be a valuation to RXNB (that we don't honestly know of yet) that needs to be provided by the audit.. See it took 18 months to go over the books of RXNB and it has been speculated (without concrete evidence) to be valued at close to $200 million dollars.. Which is far higher than where Fitx is trading today... Just how much of RXNB will be merged with Cen-bio is an important question.. But concrete numbers are needed and PR's released beforehand so we know exactly what we own come the first of March... But your math needs to be adjusted much higher if the valuation is at $200 million